Lorem Ipsum Dolor

This session includes discussions on the following topics:

• Recurrent Macular Hole Tarek S. Hassan, MD (USA)
• Internal Limiting Membrane (ILM) Flap Technique Jerzy Nawrocki, MD, PhD (Poland)
• Epiretinal Membrane (ERM) with Very Good Vision: Should One Operate? André V. Gomes, MD, PhD (Brazil)
• Epiretinal Membrane (ERM) with Lamellar Hole: When to Operate? Fumiki Okamoto, MD, PhD (Japan)
• Myopic Macular Hole: Macular vs Vitrectomy Carlos Mateo, MD (Spain)
• Chromovitrectomy: Does it Help? Michel Eid Farah, MD, PhD (Brazil)

Session Chairs: André V. Gomes, MD, PhD (Brazil); Tarek S. Hassan, MD (USA); and Virgilio Morales-Canton, MD (Mexico)

Panel: Macular Surgery

MODERATOR: Timothy G. Murray, MD, MBA, FACS (USA)

PANELISTS: Vincenzo Ferrara, MD (Italy); Jean-Pierre Hubschman, MD (USA); William E. Smiddy, MD (USA); Alexandre Ventura, MD, PhD (Brazil)

This session includes discussions on the following topics:

• When to Use Steroids for RVO: Early, Late, Never? Marcelo Zas, MD, PhD (Argentina)
• Anti-VEGF Therapy for RVO: Can Different Treatment Algorithms Change the Course of the Disease? Francisco J. Rodriguez, MD (Colombia)
• Is There Still a Role for Laser in RVO Macular Edema? Francesco Bandello, MD (Italy); Lihteh Wu, MD (Costa Rica)
• How to Use Combination Therapy for RVO Effectively Lihteh Wu, MD (Costa Rica)
• Management of Ischemia in RVO: A Modern View of Treatment Options Before and After Neovascularization is Seen Jay K. Chhablani, MD (India)
• Why Do So Many Patients Develop Chronic RVO? Pathophysiology and Outcomes Antonio Marcelo Casella, MD, PhD (Brazil)
• Yellow Micropulse Laser Therapy (577-NM) on Central Serous Chorioretinopathy Best Abstract Winner: Munir Escaf, MD (Colombia)

PANEL: Retinal Vein Occlusion—Anti-VEGF vs Anti-Inflammatory Treatment vs Laser: Can We Improve Outcomes?

MODERATOR: Sharon Fekrat, MD, FACS (USA)

PANELISTS: Arturo Alezzandrini, Jr, MD, PhD (Argentina); Amani Fawzi, MD (USA); Francisco J. Rodriguez, MD (Colombia); Jorge Rocha, MD, PhD (Brazil)

This session includes discussions on the following topics:

• Retinectomy: When and Where? Steve Charles, MD, FACS, FICS (USA)
• Silicone Oil for PVR Surgery: Pearls and Tricks Nur Acar, MD, FEBO (Turkey)
• Pharmaceutical Management of PVR Demetrios G. Vavvas, MD, PhD (USA)
• Is Scleral Buckling Necessary? Carl D. Regillo, MD, FACS (USA)
• Management of Subretinal Perfluorocarbon Liquid Marta S. Figueroa, MD, PhD (Spain)

Session Chairs: Marta S. Figueroa, MD, PhD (Spain); Tarek S. Hassan, MD (USA); and Yuichiro Ogura, MD, PhD (Japan)

PANEL: Trauma

MODERATOR: Lihteh Wu, MD (Costa Rica)

PANELISTS: Virgilio Morales-Canton, MD (Mexico); Fumiki Okamoto, MD, PhD (Japan);
Sengul Ozdek (Turkey); MD; Marcelo Zas, MD, PhD (Argentina)

This session includes discussions on the following topics:

• 3D Vitrectomy: Digital Visualization Kazuaki Kadonosono, MD, PhD (Japan)
• Vitrectomy: Fluidics/Pumps/Cut Rate Tommaso Rossi, MD (Italy)
• Advances in Illumination David R. Chow, MD, FRCS(C) (Canada)
• Artificial Vision: Everything You Need to Know Stanislao Rizzo, MD (Italy)
• Eye Injuries with Intraocular Foreign Bodies Removal Techniques Best Abstract Winner: Mohamed Tarek Moustafa MD, FRCS (Egypt)
• Flanged Intraocular Lens Fixation Best Abstract Winner: Shin Yamane, MD (Japan)Session Chairs: David R. Chow, MD, FRCS(C) (Canada); Kourous A. Rezaei, MD (USA); and Yuichiro Ogura, MD, PhD (Japan)

PANEL: New Instruments and Devices

MODERATOR: Kirk H. Packo, MD (USA)

PANELISTS: Audina M. Berrocal, MD (USA); Eugene de Juan, Jr., MD (USA); Niels Crama, MD (Netherlands); Arief S. Kartasasmita, MD (Indonesia)

This session includes discussions on the following topics:

• Chandelier Illumination for Scleral Buckling John W. Kitchens, MD (USA)
• Advances in Suprachoroidal Buckling Flavio A. Rezende, MD, PhD (Canada)
• Temporary Scleral Buckling Surgery—Back to the future? Paul E. Tornambe, MD, FACS (USA)
• Retinal Detachment with Macular Hole Marco Mura, MD (Saudi Arabia)
• ILM Peeling During Retinal Detachment Surgery: Is It Necessary? Stanislao Rizzo, MD (Italy)
• Retinoschisis-Related Retinal Detachment: Current Management Options Gaurav K. Shah, MD (USA)

Session Chairs: Ehab N. El Rayes, MD, PhD (Egypt); Kourous A. Rezaei, MD (USA); and Stanislao Rizzo, MD (Italy)

PANEL: Retinal Detachment Surgery

MODERATOR: Grazia Pertile, MD (Italy)

PANELISTS: Thomas A. Albini, MD (USA); Remzi Avci, MD (Turkey); Victor H. Gonzalez, MD (USA); Stratos Gotzaridis, MD (Greece); Raymond Iezzi, Jr., MD (USA); Jason Hsu, MD (USA)

This session includes discussions on the following topics:

• It’s a Big Broad World in There: Widefield Imaging and Optical Coherence Tomography (OCT) Netan Choudhry, MD, FRCS(C) (Canada)
• OCT Angiography Artifacts and Findings: Sometimes Dots and Doodles Mean Something (And Sometimes They Don’t!) Andre Romano, MD (Brazil)

Session Chairs: Peter K. Kaiser, MD (USA); Baruch D. Kuppermann, MD, PhD (USA); and Taiji Sakamoto, MD, PhD (Japan)

PANEL: OCT Angiography: Where Am I Using It? Has It Changed My Outcomes? What Am I Learning From It?

MODERATOR: David Sarraf, MD (USA)

PANELISTS: Pravin U. Dugel, MD (USA); K. Bailey Freund, MD (USA); Jean-Francois Korobelnik, MD (France); Luiz H. Lima, MD (Brazil)

This session includes discussions on the following topics:

• Fundus Autofluorescence: Where and When Can I Use It Most Effectively? Sophie J. Bakri, MD (USA)
• Latest in Adaptive Optics: How Soon Will the Future Arrive in Our Clinics, and What Will We Learn? Mina M. Chung, MD (USA)
• Intraoperative OCT: Is It Ready for Prime Time? Justis P. Ehlers, MD (USA)
• Choroidal Imaging: The Secrets of the Deep Revealed Aleksandra Rachitskaya (USA)
• Retinal Doppler Imaging: What We Can See and How It Helps Akitoshi Yoshida, MD, PhD (Japan)

Session Chairs: Peter K. Kaiser, MD (USA); Baruch D. Kuppermann, MD, PhD (USA); and Taiji Sakamoto, MD, PhD (Japan)

PANEL: Imaging Mysteries, Oddities, and Controversies

MODERATOR: André Romano, MD (Brazil)

PANELISTS: Claudia Acosta, MD (Colombia); Jay S. Duker, MD (USA); Luiz H. Lima, MD (Brazil); Raja Narayanan, MD, MBA (India)

This session includes discussions on the following topics:

• Emerging Therapies for Dry AMD David S. Boyer, MD (USA)
• Emerging Therapies for Neovascular AMD Peter K. Kaiser, MD (USA)
• Best Imaging Techniques for AMD David Sarraf, MD (USA)
• Toward the Development of Gene-Directed Therapeutics for AMD Gregory S. Hageman, PhD (USA)
• Biomarkers in Retina Anne Fung, MD (USA)
• Is There a Role for Steroids in AMD Management? Marc D. de Smet, MD, PhD, FRCS(C) (Switzerland)
• Pachychoroid—A Newly Recognized Risk and Disease Modifier in AMD K. Bailey Freund, MD (USA)
• Futility Algorithm in the Anti-VEGF Era David T. Wong, MD, FRCS(C) (Canada)

Session Chairs: André V. Gomes, MD, PhD (Brazil); Peter K. Kaiser, MD (USA); and Jean-François Korobelnik, MD (France)

This session includes discussions on the following topics:

• Patient-, Caregiver-, and Healthcare Provider—Reported Burden of Geographic Atrophy Best Abstract Winner: Sunil S. Patel, MD (USA)
• Gene Expression Can Be Modified by Anti-VEGF Drugs in Retinal Muller Cells in Vitro Best Abstract Winner: Javier Caceres-del-Carpio, MD (USA)

Session Chairs: André V. Gomes, MD, PhD (Brazil); Peter K. Kaiser, MD (USA); and Jean-François Korobelnik, MD (France)

PANEL: Discussion of Management of Dry and Neovascular AMD (nvAMD)—Genetics,
Treatment Styles, Etc…

MODERATOR: Peter K. Kaiser, MD (USA)

PANELISTS: David S. Boyer, MD (USA); David Pelayes, MD (Argentina); Mohammad Riazi-Esfahani, MD (Iran); Gisbert Richard, MD (Germany); Patricio Schlottmann, MD (Argentina); Eric H. Souied, MD (France)

This session includes discussions on the following topics:

• Anti-VEGF Injection and Diabetic Vitrectomy: When and Why? J. Fernando Arevalo, MD, FACS (USA)
• Advances in Traction Detachment Surgery: 27 Gauge Christopher D. Riemann, MD (USA)
• Bimanual Dissection in Traction/Rhegmatogenous Detachment (TRD/RRD): Pearls and Tricks Maria Berrocal, MD (Puerto Rico)
• ILM Peeling During Diabetic Vitrectomy: When and Why? Timothy G. Murray, MD, MBA, FACS (USA)
• Early Vitrectomy for Proliferative Diabetic Retinopathy (PDR) and Vitreous Hemorrhage Kourous A. Rezaei, MD (USA)

Session Chairs: Jean-François Korobelnik, MD (France); Sundaram Natarajan, MD, PhD (India); and Kourous A. Rezaei, MD (USA)

PANEL: Diabetic Vitrectomy

MODERATOR: Asheesh Tewari, MD (USA)

PANELISTS: Maria H. Berrocal, MD (Puerto Rico); Jay K. Chhablani, MD (India); Carl Claes, MD (Belgium); Judy E. Kim, MD (USA); Homayoun Tabandeh, MD (USA)

This session includes discussions on the following topics:

• Using Imaging to Help Diagnose Ocular Tumors Prithvi Mruthyunjaya, MD (USA)
• Future Therapeutics for Ocular Oncology Arun D. Singh, MD (USA)
• Intra-arterial Chemotherapy versus Intravenous Chemotherapy for Unilateral Retinoblastoma. Who wins? Best Abstract Winner: Carol L. Shields, MD (USA)
• Ophthalmoscopic differentiation of Coats’ Disease from Retinoblastoma Best Abstract Winner: Jerry A. Shields, MD (USA)

Session Chairs: Timothy Murray, MD (USA); and Ivana Kim, MD (USA)

PANEL: Surgical and Medical Management of Ocular Oncology Cases

MODERATOR: Carol L. Shields, MD (USA); and Jerry A. Shields, MD (USA)

PANELISTS: Rubens N. Belfort, MD, PhD (Brazil); Miguel Materin, MD (USA); Prithvi Mruthyunjaya, MD (USA)

This session includes discussions on the following topics:

• New Therapies for Retinopathy of Prematurity (ROP) Paola Dorta, MD (Chile)
• Are There Safety Concerns with Bevacizumab for ROP? Robert L. Avery, MD (USA)
• Familial Exudative Vitreoretinopathy (FEVR) Ehab N. El Rayes, MD, PhD (Egypt)
• Genetic Testing for Inherited Retinal Diseases Byron L. Lam, MD (USA)
• Gene Therapy Programs for Inherited Retinal Diseases Suber S. Huang, MD, MBA (USA)
• North Carolina Macular Dystrophy Kent W. Small, MD (USA)
• The Role of Mitochondrial Genetics on AMD Baruch D. Kuppermann, MD, PhD (USA)
• RPE 65 Injection Best Abstract Winner: Adda Villanueva, MD (Canada)

PANEL: Surgical ROP/Pediatric Case Discussion

MODERATOR: R.V. Paul Chan, MD, FACS (USA)

PANELISTS: Ehab N. El Rayes, MD, PhD (Egypt); Shunji Kusaka, MD (Japan); Hugo Quiroz-Mercado, MD (Mexico); Darius M. Moshfeghi, MD (USA); Jonathan Sears, MD (USA)

This session includes discussions on the following topics:

• Options for Secondary Intraocular Lens (IOL) Placement: Sutured, Sutureless, Iris Fixed, Anterior Chamber IOL Jeremy D. Wolfe, MD (USA)
• Autologous Retinal Transplant Updates Tamer Mahmoud, MD, PhD (USA)
• Vitrectomy in the Endophthalmitis Patient Harry W. Flynn, Jr, MD (USA)
• Vitreomacular Interface Diseases and their Management Susanne Binder, MD (Austria)
• Tractional Detachments—Viscodissection, En Bloc Dissection with Small Gauge, Perfluoro-N-Octane (PFO) Maria H. Berrocal, MD (Puerto Rico)

Session Chairs: Marta S. Figueroa, MD, PhD (Spain); Tarek S. Hassan, MD (USA); and Stanislao Rizzo, MD (Italy)

PANEL: Surgical Cases

MODERATOR: Sunir J. Garg, MD, FACS (USA)

PANELISTS: André Maia, MD (Brazil); Mostafa Nabih, MD (Egypt); Raja Narayanan, MD, MBA (India); Ogugua N. Okonkwo, MD, FRCS(Edin), FWACS (Nigeria);
David T. Wong, MD, FRCS(C) (Canada)

This session includes opposing viewpoint discussions on the following:

• Steroids Have Similar Effects on Diabetic Retinopathy as Anti-VEGF—Pro/Con Baruch D. Kuppermann, MD and Anat Loewenstein
• Routine Dosing (e.g. Monthly) for Anti-VEGF—Pro/Con • Nancy M. Holekamp, MD (USA) and Alejandro J. Lavaque, MD (Argentina)
  
• Bevacizumab Is as Good as Ranibizumab and Aflibercept for AMD—Pro/Con Daniel F. Martin, MD (USA) and Carl W. Baker, MD (USA)
  
• Bevacizumab Is as Good as Ranibizumab and Aflibercept for DME—Pro/Con • Mario Saravia, MD (Argentina) and Jean-François Korobelnik, MD (France)
  
• Intraoperative OCT Is Ready for Prime Time—Pro/Con Rene Cano Hidalgo, MD (Mexico) and Virgilio Morales-Canton, MD (Mexico)
  
• OCT Angiography Is Ready for Prime Time—Pro/Con • Jay S. Duker, MD (USA) and Jans Fromow-Guerra, MD, MSc, PhD (Mexico)
  

Session Chairs: David R. Chow, MD, FRCS(C) (Canada); Pravin U. Dugel, MD (USA); and Jorge Rocha, MD, PhD (Brazil)

This session includes discussions on the following topics:

• Floaterectomy—Pro/Con Jorge Fortun, MD (USA) and Osias F. Souza, MD (Brazil)
• Perfluorocarbon Is Necessary for Retinal Surgery—Pro/Con • Grazia Pertile, MD (Italy) and Marcos Ávila, MD, PhD (Brazil)
• ILM Peeling for Macular Cases Including Macular Holes—Pro/Con Mauricio Maia, MD, PhD (Brazil) and Andres Bastien, MD (Argentina)
• Facedown Positioning for Macular Hole Surgery—Pro/Con John S. Pollack, MD (USA) and Shwu-Jiuan Sheu, MD (Taiwan)
• Indocyanine Green (ICG) for Staining ILM—Pro/Con Jose A. Roca, MD (Peru) and Eduardo B. Rodrigues, MD (Brazil)
• Laser Should Be First Line Therapy for Proliferative Diabetic Retinopathy (PDR) Paulo E. Stanga, MD (UK)
• Anti-VEGF Should Be First Line Therapy for Proliferative Diabetic Retinopathy (PDR) Marcio B. Nehemy, MD, PhD (Brazil) Session Chairs: David R. Chow, MD, FRCS(C) (Canada); Pravin U. Dugel, MD (USA); and Jorge Rocha, MD, PhD (Brazil)

This session includes discussions on the following topics:

• Remarkable Findings from Anti-VEGF for DME Studies—RISE/RIDE and VIVID/VISTA Marco A. Zarbin, MD, PhD (USA)
• Remarkable Findings from Steroids DME Studies—FAME, REINFORCE Study Rishi P. Singh, MD (USA)
• Vitrectomy in Diabetic Macular Edema Patients (ICV-DME) Maurice B. Landers, III, MD (USA)
• Is Laser for DME and DR Dead? Micropulse and Insights from Recent Studies Elias Reichel, MD (USA)
• RG7716- A Novel Bispecific Anti-VEGF/Anti-Angiopoietin-2 Monoclonal Antibody for Neovascular
• Age-related Macular Degeneration and Diabetic Macular Edema Best Abstract Winner: Pravin U. Dugel, MD (USA)
• Characteristics of Patients with Diabetic Macular Edema Treated with Anti-VEGF Agents According to the Vitreomacular Interface Best Abstract Winner: Marcio B. Nehemy, MD (Brazil)
  

Session Chairs: Ehab N. El Rayes, MD, PhD (Egypt); Virgilio Morales-Canton, MD (Mexico); Baruch D. Kuppermann, MD, PhD (USA); and Young Hee Yoon, MD (Korea); Marco A. Zarbin, MD, PhD (USA); Rishi P. Singh, MD (USA); Maurice B. Landers, III, MD (USA); Elias Reichel, MD (USA)

Speakers: Marco A. Zarbin, MD, PhD (USA); Rishi P. Singh, MD (USA); Maurice B. Landers, III, MD (USA); Elias Reichel, MD (USA); and Best Abstract Winners, Pravin U. Dugel, MD (USA); and Marcio B. Nehemy, MD (Brazil)

PANEL: Anti-VEGF/Steroid Face-Off—Which Would You Choose?

MODERATOR: Michaella Goldstein, MD (Israel)

PANELISTS: Francesco Boscia, MD (Italy); Michael Singer, MD (USA); Patricia Udaondo, MD (Spain); Nadia K. Waheed, MD, MPH (USA)

This session includes discussions on the following topics:

• Future DME TherapeuticsJustus G. Garweg, MD (Switzerland)
• New Insights into Imaging DME and DR: Where Are We, and Where Are We Going? Richard B. Rosen, MD, DSc(Hon) (USA)
• OCT Angiography for DME—Does It Give Us a New Understanding of Pathophysiology and Facilitate Outcomes? Nadia K. Waheed, MD, MPH (USA)
• Identifying Treatment Failures in DME Patricia Udaondo, MD (Spain)

Session Chairs: Ehab N. El Rayes, MD, PhD (Egypt); Virgilio Morales-Canton, MD (Mexico); Baruch D. Kuppermann, MD, PhD (USA); and Young Hee Yoon, MD (Korea)

PANEL: Case Discussion Based on DRCRnet Trials

MODERATOR: Andrew Antoszyk, MD (USA)

PANELISTS: Carl W. Baker, MD (USA); Francesco Bandello, MD (Italy); Michael Kapusta, MD (Canada); Acacio Muralha Neto, MD, MBA (Brazil); John A. Wells III, MD, FACS (USA)

Session Chairs: Arturo Alezzandrini, Jr, MD, PhD (Argentina); Kourous A. Rezaei, MD (USA); and Taiji Sakamoto, MD, PhD (Japan)

This session includes discussions by the following panelists:

Carl Claes, MD (Belgium); Kirk H. Packo, MD, FACS (USA); Khalid Sabti, MD, FRCS(C) (Kuwait); Fabio Patelli, MD (Italy); André Maia, MD (Brazil); Motohiro Kamei, MD, PhD (Japan)

PANEL: New Therapeutics for Uveitis and Best Uveitis Cases

MODERATOR: Sunil K. Srivastava, MD (USA)

PANELISTS: Thomas A. Albini, MD (USA); Sumit Sharma, MD (USA); Pauline T. Merrill, MD (USA); Steven Yeh, MD (USA); Raul NG Vianna, MD (Brazil)

This session includes discussions on the following topics:

• Anti-PDGF in nvAMD: An Analysis of the Latest Trial Results Pravin U. Dugel, MD (USA)
• Ranibizumab Treatment was Superior to Verteporfin Photodynamic Therapy for Myopic Choroidal Neovascularization (mCNV): Results from the Prospective, Randomized, Double-Masked European RADIANCE Trial Nathan C. Steinle, MD (USA)
• Study Assessing Double-Masked Uveitis Treatment Study 2 Pauline T. Merrill, MD (USA)
• Abicipar Pegol Phase 3 AMD Studies Pravin U. Dugel, MD (USA)
• Suprachoroidal Treatment of Macular Edema Associated with RVO Mark R. Barakat, MD (USA)
  
• REINFORCE Study Michael Singer, MD (USA)

Session Chairs: Pravin U. Dugel, MD (USA); Sundaram Natarajan, MD, PhD (India); and Young Hee Yoon, MD (Korea)

Speakers: Nathan C. Steinle, MD (USA); Pauline T. Merrill, MD (USA); Mark R. Barakat, MD (USA); Michael Singer, MD (USA)